Join
Live feed
·
INSIDERFilingvia Quantisnow
Acurx Pharmaceuticals Inc. logo

Director Donohue James J. bought $10,000 worth of shares (9,852 units at $1.01), increasing direct ownership by 79% to 22,352 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ACXP· Acurx Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACXP (Acurx Pharmaceuticals Inc.) and more on Quantisnow.